These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2698272)

  • 1. A double-blind comparative study: amineptine (Survector 100) versus imipramine.
    Mendis N; Hanwella DR; Weerasinghe C; Illesinghe DS; De Silva D
    Clin Neuropharmacol; 1989; 12 Suppl 2():S58-65. PubMed ID: 2698272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amineptine versus imipramine. Double-blind controlled study].
    Oules J; Boscredon J
    Presse Med; 1983 Oct; 12(36):2243-6. PubMed ID: 6226963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter Italian study of amineptine (Survector 100).
    Kemali D
    Clin Neuropharmacol; 1989; 12 Suppl 2():S41-50. PubMed ID: 2698270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of thymo-analeptics and acceptability of amineptin compared to those of imipramine].
    Ropert R; Barte HN; Ostaptzeff G; Kamoun A
    Encephale; 1982; 8(3):389-403. PubMed ID: 7186460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of amineptine (Survector 100) in the treatment of depression: preliminary results of an Indian multicenter trial.
    Boral GC; Shah LP
    Clin Neuropharmacol; 1989; 12 Suppl 2():S51-7. PubMed ID: 2698271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amineptine in the prevention of relapse in unipolar depression.
    Ferreri M; Colonna L; Leger JM
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S39-45. PubMed ID: 9347392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in elderly people treated with amineptine (Survector 100): a synopsis.
    Marconi PL; Brugnoli R; Bressa GM
    Clin Neuropharmacol; 1989; 12 Suppl 2():S97-105. PubMed ID: 2698275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients.
    Macher JP; Mirabaud C
    Psychopharmacology (Berl); 1992; 106 Suppl():S116-7. PubMed ID: 1546123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome.
    Alevizos B; Christodoulou GN; Ioannidis C; Voulgari A; Mantidis A; Spiliadis C
    Clin Neuropharmacol; 1989; 12 Suppl 2():S66-76. PubMed ID: 2698273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.
    Katona C; Bercoff E; Chiu E; Tack P; Versiani M; Woelk H
    J Affect Disord; 1999 Oct; 55(2-3):203-13. PubMed ID: 10628889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind clinical trial of the antidepressant action of amineptine.
    van Amerongen P
    Curr Med Res Opin; 1979; 6(2):93-100. PubMed ID: 380915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind trial of amineptine and clomipramine in the treatment of depression.
    Lemoine P; Achaintre A; Balvay G; Bonnet H; Burgat R; Carrier C; Perrin J
    Curr Med Res Opin; 1981; 7(4):234-40. PubMed ID: 7014104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
    Dalery J; Rochat C; Peyron E; Bernard G
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Objective evaluation of the effectiveness of amineptine in the treatment of severe depressive states using the Hamilton depression scale].
    Van Amerongen P
    Encephale; 1978; 4(2):131-43. PubMed ID: 688972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
    Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cardiovascular effects of amineptine with those of amitriptyline and imipramine in anaesthetized rats.
    Balcioglu A; Bozkurt A; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1991; 309():64-74. PubMed ID: 1888231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid changes in 3H-imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients.
    Gronier B; Jeanningros R
    Fundam Clin Pharmacol; 1992; 6(2):89-95. PubMed ID: 1607147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.
    Rampello L; Nicoletti G; Raffaele R; Drago F
    Neuropsychobiology; 1995; 31(3):130-4. PubMed ID: 7609861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.